127 related articles for article (PubMed ID: 36535461)
21. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells.
Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS
Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma.
Huang H; Wang X; Zhang S; Bai X; Griffin N; Shan Y; Shan F
Int Immunopharmacol; 2023 Dec; 125(Pt B):111226. PubMed ID: 37976597
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D enhances the sensitivity of breast cancer cells to the combination therapy of photodynamic therapy and paclitaxel.
Liu X; Lv H; Shen H
Tissue Cell; 2022 Aug; 77():101815. PubMed ID: 35623307
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanism of cell apoptosis by paclitaxel and pirarubicin in a human osteosarcoma cell line.
Liu SY; Song SX; Lin L; Liu X
Chemotherapy; 2010; 56(2):101-7. PubMed ID: 20357441
[TBL] [Abstract][Full Text] [Related]
25. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel.
Aghajani M; Mokhtarzadeh A; Aghebati-Maleki L; Mansoori B; Mohammadi A; Safaei S; Asadzadeh Z; Hajiasgharzadeh K; Khaze Shahgoli V; Baradaran B
Mol Biol Rep; 2020 May; 47(5):3691-3703. PubMed ID: 32246247
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis induced by chamaejasmine in human osteosarcoma cells through p53 pathway.
Yang D; Wang P; Ren X
Tumour Biol; 2015 Jul; 36(7):5433-9. PubMed ID: 25677904
[TBL] [Abstract][Full Text] [Related]
27. Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration.
Najafzadeh B; Motafakkerazad R; Najafi S; Amini M; Alemohammad H; Vasefifar P; Baradaran B
Pathol Res Pract; 2022 May; 233():153869. PubMed ID: 35398618
[TBL] [Abstract][Full Text] [Related]
28. Influence of β-catenin small interfering RNA on human osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):353-358. PubMed ID: 21671177
[TBL] [Abstract][Full Text] [Related]
29. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
30. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
31. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
Zhu KP; Zhang CL
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
[No Abstract] [Full Text] [Related]
32. MicroRNA-190b inhibits tumor cell proliferation and induces apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells.
Kang M; Xia P; Hou T; Qi Z; Liao S; Yang X
Pharmazie; 2017 May; 72(5):279-282. PubMed ID: 29441873
[TBL] [Abstract][Full Text] [Related]
33. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
Duo J; Ma Y; Wang G; Han X; Zhang C
DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
[TBL] [Abstract][Full Text] [Related]
34. [RNAi-mediated knockdown of cyclooxygenase 2 inhibits the growth and migration of SaOS2 human osteosarcoma cells].
Liu Z; Wu XZ; Song R; Zong XF; Ru L; Li K; Zhao QH
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):1028-31. PubMed ID: 23886271
[TBL] [Abstract][Full Text] [Related]
35. [Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS].
Ye ZM; Miao XD; Yang DS; Xu RZ; Huang X; Ge FF
Ai Zheng; 2005 Mar; 24(3):298-304. PubMed ID: 15757530
[TBL] [Abstract][Full Text] [Related]
36. Cancer combination therapies by silencing of CTLA-4, PD-L1, and TIM3 in osteosarcoma.
Sorkhabi AD; Sarkesh A; Fotouhi A; Saeedi H; Aghebati-Maleki L
IUBMB Life; 2022 Sep; 74(9):908-917. PubMed ID: 35638098
[TBL] [Abstract][Full Text] [Related]
37. Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
Liang CZ; Zhang JK; Shi Z; Liu B; Shen CQ; Tao HM
Cancer Chemother Pharmacol; 2012 Feb; 69(2):317-31. PubMed ID: 21717192
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
39. RNAi-mediated knockdown of ERK1/2 inhibits cell proliferation and invasion and increases chemosensitivity to cisplatin in human osteosarcoma U2-OS cells in vitro.
Si H; Peng C; Li J; Wang X; Zhai L; Li X; Li J
Int J Oncol; 2012 Apr; 40(4):1291-7. PubMed ID: 22179790
[TBL] [Abstract][Full Text] [Related]
40. Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.
Chen D; Chen W; Xu Y; Zhu M; Xiao Y; Shen Y; Zhu S; Cao C; Xu X
J Med Genet; 2019 Jan; 56(1):43-49. PubMed ID: 29967134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
